FDA.reportPublic FDA data

1 ML mosunetuzumab-axgb 45 MG/ML Injection

RxCUI
2729433
RxNorm name
1 ML mosunetuzumab-axgb 45 MG/ML Injection
Display name
1 ML mosunetuzumab-axgb 45 MG/ML Injection
Full name
1 ML mosunetuzumab-axgb 45 MG/ML Injection
Term type
SCD
Status
DailyMed mapping
Updated
2026-06-04 23:39:02

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
761263Lunsumiomosunetuzumab-axgb351(a)Rx2026-07-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Lunsumio VeloMOSUNETUZUMABGenentech, Inc.6a2b6dc2-48bd-4da7-a611-bc6bae2893c82026-06-29Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 2729433

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
6a2b6dc2-48bd-4da7-a611-bc6bae2893c8mosunetuzumab-axgb 45 MG in 1 ML Injection [PSN] · 1 ML mosunetuzumab-axgb 45 MG/ML Injection [SCD] · mosunetuzumab-axgb 45 MG per 1 ML Injection [SY] · mosunetuzumab-axgb 45 MG/ML per 1 ML Injection [SY]43These highlights do not include all the information needed to use LUNSUMIO VELO safely and effectively. See full prescribing information for LUNSUMIO VELO. LUNSUMIO VELO™ (mosunetuzumab-axgb) injection, for subcutaneous use Initial U.S. Approval: 202220251219